Oxymorphone

Generic Name
Oxymorphone
Brand Names
Opana
Drug Type
Small Molecule
Chemical Formula
C17H19NO4
CAS Number
76-41-5
Unique Ingredient Identifier
9VXA968E0C
Background

An opioid analgesic with actions and uses similar to those of morphine, apart from an absence of cough suppressant activity. It is used in the treatment of moderate to severe pain, including pain in obstetrics. It may also be used as an adjunct to anesthesia (From Martindale, The Extra Pharmacopoeia, 30th ed, p1092). On June 8, 2017, FDA requested Endo Pharm...

Indication

For the treatment of moderate-to-severe pain.

Associated Conditions
Anxiety, Severe Pain, Moderate Pain
Associated Therapies
Perioperative analgesia, Obstetrical analgesia therapy
Clinical Trials
Related News

Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer

First Posted Date
2018-07-06
Last Posted Date
2024-06-18
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
43
Registration Number
NCT03579446
Locations
🇺🇸

M D Anderson Cancer Center, Houston, Texas, United States

Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis

Not Applicable
Completed
Conditions
Postoperative Nausea and Vomiting
Interventions
Procedure: Automated recommendation at the start of the case
Procedure: Automated notification at the start of surgery
Procedure: Automated notification at the end of surgery
Device: Anesthesia Information Management System (AIMS)
Device: Perioperative Data Warehouse (PDW)
Procedure: General anesthesia
Procedure: Elective surgery
Drug: Propofol
Drug: Sevoflurane
Drug: Isoflurane
Drug: Desflurane
Drug: Scopolamine
Drug: Droperidol
Drug: Haloperidol
Drug: Dexamethasone
Drug: Promethazine
Drug: Meclizine
Drug: Aprepitant
Drug: Metoclopramide
Drug: Fentanyl
Drug: Sufentanil
Drug: Alfentanil
Drug: Remifentanil
Drug: Morphine
Drug: Meperidine
Drug: Hydromorphone
Drug: Methadone
Drug: Oxycodone
Drug: Oxymorphone
Drug: Hydrocodone
Drug: Ketamine
Drug: Ondansetron
Drug: Granisetron
Drug: Dolasetron mesylate
Drug: Palonosetron
Drug: Tropisetron
Drug: Ramosetron
First Posted Date
2015-12-09
Last Posted Date
2019-03-07
Lead Sponsor
Vanderbilt University
Target Recruit Count
27034
Registration Number
NCT02625181
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Bioequivalency Study of Oxymorphone Hydrochloride 10 mg Tablets Under Fasted Conditions

Phase 1
Completed
Conditions
Pain
Interventions
Drug: Oxymorphone
First Posted Date
2010-09-28
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
42
Registration Number
NCT01210638
Locations
🇺🇸

Novum Pharmaceutical Research Services, Houston, Texas, United States

Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fasted Conditions

Phase 1
Completed
Conditions
Pain
Interventions
Drug: Oxymorphone
First Posted Date
2009-03-06
Last Posted Date
2017-03-29
Lead Sponsor
Sandoz
Target Recruit Count
50
Registration Number
NCT00857428

Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fed Conditions

Phase 1
Completed
Conditions
Pain
Interventions
Drug: oxymorphone hydrochloride
Drug: Opana
First Posted Date
2009-03-06
Last Posted Date
2017-03-29
Lead Sponsor
Sandoz
Target Recruit Count
32
Registration Number
NCT00857142

A Pilot Study of Switching From One Pain Medication to Another (Opioid Rotation)

Not Applicable
Completed
Conditions
Pain
Interventions
Drug: Oxymorphone
First Posted Date
2007-12-24
Last Posted Date
2016-02-03
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
12
Registration Number
NCT00580294
Locations
🇺🇸

Icahn School of Medcine at Mount Sinai, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy